These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 10818407

  • 1. Insulin sensitizers and antiandrogens in the treatment of polycystic ovary syndrome.
    Diamanti-Kandarakis E, Zapanti E.
    Ann N Y Acad Sci; 2000; 900():203-12. PubMed ID: 10818407
    [Abstract] [Full Text] [Related]

  • 2. Insulin sensitizers for polycystic ovary syndrome.
    Baillargeon JP, Iuorno MJ, Nestler JE.
    Clin Obstet Gynecol; 2003 Jun; 46(2):325-40. PubMed ID: 12808383
    [No Abstract] [Full Text] [Related]

  • 3. The polycystic ovary syndrome: treatment with insulin sensitizing agents.
    Iuorno MJ, Nestler JE.
    Diabetes Obes Metab; 1999 May; 1(3):127-36. PubMed ID: 11220291
    [No Abstract] [Full Text] [Related]

  • 4. [Troglitazone for treatment of polycystic ovary syndrome].
    Sanaka M, Iwamoto Y.
    Nihon Rinsho; 2000 Feb; 58(2):465-70. PubMed ID: 10707578
    [Abstract] [Full Text] [Related]

  • 5. Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.
    Kuscu NK, Koyuncu FM.
    Medscape Womens Health; 2002 Feb; 7(5):3. PubMed ID: 12466732
    [Abstract] [Full Text] [Related]

  • 6. Thiazolidinediones for treatment of polycystic ovary syndrome.
    Stout DL, Fugate SE.
    Pharmacotherapy; 2005 Feb; 25(2):244-52. PubMed ID: 15767238
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of PCOS without IVF: weight loss, insulin-sensitizing agents].
    Pugeat M.
    J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(3 Pt 2):S25-9. PubMed ID: 12773915
    [No Abstract] [Full Text] [Related]

  • 8. Use of insulin-sensitizing agents in patients with polycystic ovary syndrome.
    Bloomgarden ZT, Futterweit W, Poretsky L.
    Endocr Pract; 2001 Feb; 7(4):279-86. PubMed ID: 11497481
    [Abstract] [Full Text] [Related]

  • 9. Insulin-sensitizing agents in polycystic ovary syndrome.
    Pasquali R, Gambineri A.
    Eur J Endocrinol; 2006 Jun; 154(6):763-75. PubMed ID: 16728533
    [Abstract] [Full Text] [Related]

  • 10. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.
    Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3299-306. PubMed ID: 8784087
    [Abstract] [Full Text] [Related]

  • 11. Troglitazone use in polycystic ovary syndrome.
    Landman RE, Jacobs TP.
    J Clin Endocrinol Metab; 2001 Oct; 86(10):5090-1. PubMed ID: 11600596
    [No Abstract] [Full Text] [Related]

  • 12. Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome.
    Hasegawa I, Murakawa H, Suzuki M, Yamamoto Y, Kurabayashi T, Tanaka K.
    Fertil Steril; 1999 Feb; 71(2):323-7. PubMed ID: 9988406
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Polycystic ovary syndrome: treatment with insulin-sensitizing agents].
    Laboureau-Soares Barbosa S, Rodien P, Rohmer V.
    Ann Endocrinol (Paris); 2002 Feb; 63(1):31-5. PubMed ID: 11937980
    [Abstract] [Full Text] [Related]

  • 15. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications.
    Nestler JE.
    Semin Reprod Endocrinol; 1997 May; 15(2):111-22. PubMed ID: 9165656
    [Abstract] [Full Text] [Related]

  • 16. Insulin-sensitising agents in polycystic-ovary syndrome.
    Sattar N, Hopkinson ZE, Greer IA.
    Lancet; 1998 Jan 31; 351(9099):305-7. PubMed ID: 9652605
    [No Abstract] [Full Text] [Related]

  • 17. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial.
    Azziz R, Ehrmann D, Legro RS, Whitcomb RW, Hanley R, Fereshetian AG, O'Keefe M, Ghazzi MN, PCOS/Troglitazone Study Group.
    J Clin Endocrinol Metab; 2001 Apr 31; 86(4):1626-32. PubMed ID: 11297595
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The role of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.
    Katsiki N, Georgiadou E, Hatzitolios AI.
    Drugs; 2009 Jul 30; 69(11):1417-31. PubMed ID: 19634921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.